Original Research
Accepted on 18 Apr 2025
Harmine derivative B-9-3 inhibits non-small cell lung cancer via the VEGFA/PI3K/AKT pathway
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1526952
- 146 views
Type at least 3 characters
26,238 articles
Original Research
Accepted on 18 Apr 2025
Bioactive Lipids and Allelopathic Potential of the Invasive Plant Heracleum sosnowskyi: Insights into Its Fatty Acid Composition, Antimicrobial and Cytotoxic Effects
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1582694
Original Research
Accepted on 18 Apr 2025
Serum 25(OH)D and plasma fatty acids on breast and gastric tumors: A cross-sectional study in Northeast China
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1567568
Editorial
Accepted on 18 Apr 2025
Advancements in Sex-Specific Tumor Heterogeneity
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1598740
General Commentary
Accepted on 18 Apr 2025
Commentary: Triclabendazole Induces Pyroptosis by Activating Caspase-3 to Cleave GSDME in Breast Cancer Cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1583920
Case Report
Accepted on 18 Apr 2025
Crizotinib for ROS1 SCLC Case report: Durable response of immuno-chemotherapy targeting a rare ROS1 fusion-positive extensive-stage SCLC patient after primary resistance to crizotinib
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1522542
Original Research
Accepted on 17 Apr 2025
Apigenin promotes melanogenesis and melanosome transport through the c-KIT/Raf-1/MAPK/CREB pathway in HEMCs
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1572878
- 130 views
Original Research
Accepted on 17 Apr 2025
Resveratrol and N-acetylcystein reduce hepatic steatosis but enhance initiation and progression of hepatocellular carcinoma by inhibiting GST-pi-MAPK axis in mice
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1574039
- 118 views
Original Research
Accepted on 17 Apr 2025
Therapeutic Potential of Zinc 64 Zn Aspartate for Obesity Management: Impact on Oxidative Stress, Lipid Metabolism, Pancreas and Liver in High-Calorie Diet Model
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1543166
- 107 views
Review
Accepted on 17 Apr 2025
Modulating mitochondria with Natural Extract Compound: from bench to clinical therapeutic opportunities for COPD
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1531302
- 240 views
Original Research
Accepted on 17 Apr 2025
Renal tubular epithelial cell related partial epithelial-mesenchymal transition in AAâ… induced renal fibrosis via Wnt7b/β-catenin signaling
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1571960
Editorial
Accepted on 17 Apr 2025
Diabetic Kidney Disease: Routes to drug development, pharmacology and underlying molecular mechanisms, Volume II
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1609100
- 112 views
Original Research
Accepted on 17 Apr 2025
Exploring Indigenous Knowledge and Practices of the Gurage Community on the Biosystematics and Utilization of Enset Landraces for Bone Fracture and Regeneration: The case of Gurage zone, Central Ethiopia Region
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1563898
- 110 views
Original Research
Accepted on 17 Apr 2025
Nafamostat Mesylate Augments Survival in Rats Afflicted by Exertional Heat Stroke
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1559181
Original Research
Accepted on 17 Apr 2025
Berberine in the Treatment of Radiation-Induced Skin Injury: Insights from Proteomics and Network Pharmacology
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1542851
Original Research
Accepted on 17 Apr 2025
Longitudinal relationships between serum ferritin and prognosis among severe community-acquired pneumonia patients
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1556185